David Meek

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
David Meek's trades of Swedish Orphan Biovitrum AB (publ)'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-25 2026-03-23 B Purchase
97,375
317.20
US$4,277,844
97,375 317.20 US$4,277,844
2026-03-25 2026-03-23 B Purchase
27,104
461.18
US$2,005,672
27,104 461.18 US$2,005,672